Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,533,616
+$1,746,490 QoQ
Shares Held
170,270
+83.0% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 294 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Jun 30, 2024CallValue
$548,418
CallShares
15,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. BHVN ranks #84 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in BHVN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,533,616 | 170,270 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $787,126 | 93,041 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,710,614 | 151,516 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,683,024 | 112,127 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,488,124 | 105,466 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,467,872 | 102,657 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,630,327 | 43,650 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,669,895 | 33,418 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $548,418 | 15,800 | Call | Defined | 2024-08-13 | |
| 2024-06-30 | $1,221,166 | 35,182 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,947,453 | 35,609 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,039,525 | 24,288 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,322,196 | 89,281 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,383,698 | 57,847 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,036,709 | 75,894 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $42,513 | 3,063 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||